117 related articles for article (PubMed ID: 8535189)
1. What is ineffective erythropoiesis in myelodysplastic syndromes?
Bowen D
Leuk Lymphoma; 1995 Jul; 18(3-4):243-7. PubMed ID: 8535189
[TBL] [Abstract][Full Text] [Related]
2. Cytometric analysis and maturation characteristics of reticulocytes from myelodysplastic patients.
Bowen D; Williams K; Phillips I; Cavill I
Clin Lab Haematol; 1996 Sep; 18(3):155-60. PubMed ID: 8939385
[TBL] [Abstract][Full Text] [Related]
3. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
4. Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.
Watanabe K; Kawai Y; Takeuchi K; Shimizu N; Iri H; Ikeda Y; Houwen B
J Clin Pathol; 1994 Aug; 47(8):736-9. PubMed ID: 7962628
[TBL] [Abstract][Full Text] [Related]
5. Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Huang H; Xu C; Gao J; Li B; Qin T; Xu Z; Ren S; Zhang Y; Jiao M; Qu S; Pan L; Hu N; Liu J; Cai W; Zhang Y; Wu D; Zhang P; Gale RP; Huang G; Zhou J; Shi L; Xiao Z
Blood Cancer J; 2020 Aug; 10(8):83. PubMed ID: 32801296
[TBL] [Abstract][Full Text] [Related]
6. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs).
Poli A; Ratti S; Finelli C; Mongiorgi S; Clissa C; Lonetti A; Cappellini A; Catozzi A; Barraco M; Suh PG; Manzoli L; McCubrey JA; Cocco L; Follo MY
FASEB J; 2018 Feb; 32(2):681-692. PubMed ID: 28970249
[TBL] [Abstract][Full Text] [Related]
8. Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?
Cortelezzi A; Cattaneo C; Cristiani S; Duca L; Sarina B; Deliliers GL; Fiorelli G; Cappellini MD
Hematol J; 2000; 1(3):153-8. PubMed ID: 11920184
[TBL] [Abstract][Full Text] [Related]
9. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis.
Choi JW
Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730
[No Abstract] [Full Text] [Related]
10. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
Raimbault A; Pierre-Eugene C; Rouquette A; Deudon C; Willems L; Chapuis N; Mathis S; Kunz C; Fricke H; Kosmider O; Bardet V; Fontenay M;
Oncotarget; 2016 Mar; 7(12):14898-911. PubMed ID: 26910909
[TBL] [Abstract][Full Text] [Related]
11. A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.
Elvarsdóttir EM; Mortera-Blanco T; Dimitriou M; Bouderlique T; Jansson M; Hofman IJF; Conte S; Karimi M; Sander B; Douagi I; Woll PS; Hellström-Lindberg E
Leukemia; 2020 Jan; 34(1):271-282. PubMed ID: 31375745
[TBL] [Abstract][Full Text] [Related]
12. Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia.
Cappellini MD; Taher AT; Verma A; Shah F; Hermine O
Blood Rev; 2023 May; 59():101039. PubMed ID: 36577601
[TBL] [Abstract][Full Text] [Related]
13. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes.
Zhang Q; Steensma DP; Yang J; Dong T; Wu MX
Leukemia; 2019 Jan; 33(1):217-229. PubMed ID: 30050123
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
[TBL] [Abstract][Full Text] [Related]
17. Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes.
Jiang H; Yang L; Guo L; Cui N; Zhang G; Liu C; Xing L; Shao Z; Wang H
Oxid Med Cell Longev; 2018; 2018():6328051. PubMed ID: 29967662
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
[TBL] [Abstract][Full Text] [Related]
20. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
